Target intelligence / Profile preview

Plasmodium gametocyte transmission processes

Molecular classification
Other
01

Overview

Plasmodium gametocyte transmission processes refer to the complex biological stages required for the malaria parasite to transition from the human host to the Anopheles mosquito vector (NIH, 2021). This sequence begins with gametocytogenesis, where a subset of asexual blood-stage parasites differentiates into male and female gametocytes, followed by their maturation and circulation in the peripheral blood (MDPI, 2022). Upon ingestion by a mosquito, these gametocytes undergo gametogenesis, fertilization, and development into ookinetes and oocysts, eventually producing sporozoites for the next infection (NIH, 2023). These processes represent a critical population bottleneck, making them prime targets for transmission-blocking drugs and vaccines (NIH, 2019). Therapeutic agents like primaquine and methylene blue act as gametocytocidals, while experimental vaccines target surface proteins such as Pfs25 and Pfs230 to prevent parasite development within the mosquito (Semanticscholar, 2016). Interrupting these processes is a cornerstone of malaria elimination strategies, as it prevents the spread of the parasite even if it does not directly alleviate the symptoms of the infected individual (Frontiers, 2020).

Other names
GametocytogenesisGametogenesisSporogonyTransmission-blockingMalaria transmission cycle
02

Mechanism of action

Interruption of the parasite life cycle by killing sexual stages (gametocytes) or preventing their development, activation, and fertilization within the mosquito vector (NIH, 2019; MDPI, 2022).

03

Biological functions

Cell differentiationReproductionInfectionCellular development
04

Disease associations

Infection
05

Safety considerations

Hemolytic anemia in G6PD-deficient patients (primaquine) (NIH, 2019)Altruistic nature of treatment (no direct clinical benefit to the treated individual) (NIH, 2023)Potential for drug-induced increase in sexual commitment (Frontiers, 2020)
06

Interacting drugs

Primaquine

6 more in the full profile.

07

Biomarkers

Gametocyte density (NIH, 2021)Exflagellation rate (NIH, 2021)Oocyst count (NIH, 2019)Transmission-blocking activity (TBA) (MDPI, 2022)

Beyond the preview

Go deeper on Plasmodium gametocyte transmission processes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plasmodium gametocyte transmission processes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call